BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 26774329)

  • 41. [Structural and functional properties and the biological activity of Yersinia pestis capsular antigen, murine toxin and endotoxin].
    Isin ZhM; Tugambaev TI
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Apr; (4):91-8. PubMed ID: 3300112
    [No Abstract]   [Full Text] [Related]  

  • 42. [Cyclic nucleotides in the dynamic development of shock caused by the murine toxin of Yersinia pestis].
    Cherkasova TD; Vengrov PR; Melikhov VI; Avrorov VP; Iurkiv VA
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Jul; (7):70-4. PubMed ID: 2823509
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Characteristics of the acid-alkali equilibrium in blood of experimental animals in response to exposure of 'murine' toxin and Yersinia pestis capsular antigen].
    Kagramanov VS; Aseeva LE; Vagner VP
    Zh Mikrobiol Epidemiol Immunobiol; 2001; (3):8-11. PubMed ID: 11550568
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Molecular organization and functions of the protein toxins of the causative agents of cholera and plague].
    Efremenko VI
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Nov; (11):7-13. PubMed ID: 6362301
    [No Abstract]   [Full Text] [Related]  

  • 45. [Transfer of the sex episome from Escherichia coli to Pasteurella pestis].
    MARTIN G; JACOB F
    C R Hebd Seances Acad Sci; 1962 May; 254():3589-90. PubMed ID: 14470366
    [No Abstract]   [Full Text] [Related]  

  • 46. Properties and pharmacological action of plague murine toxin.
    Montie TC
    Pharmacol Ther; 1981; 12(3):491-9. PubMed ID: 7025029
    [No Abstract]   [Full Text] [Related]  

  • 47. [Evaluation of hypoxic state in experimental animals induced by Yersinia pestis antigens].
    Kagramanov VS; Aseeva LE; Goncharov EK
    Zh Mikrobiol Epidemiol Immunobiol; 2002; (5):65-7. PubMed ID: 12525005
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Studies on the mechanism of circulatory failure induced in rats by Pasteurella pestis murine toxin.
    Hildebrand GJ; Ng J; Von Metz EK; Eisler DM
    J Infect Dis; 1966 Dec; 116(5):615-29. PubMed ID: 5957268
    [No Abstract]   [Full Text] [Related]  

  • 49. Isolation of toxic subunits from two murine-toxic proteins from Pasturella pestis.
    Montie TC; Montie DB; Leon SA; Kennedy CA; Ajl SJ
    Biochem Biophys Res Commun; 1968 Nov; 33(3):423-9. PubMed ID: 5722234
    [No Abstract]   [Full Text] [Related]  

  • 50. The murine toxin of Pasteurella pestis: a study in its development.
    Kadis S; Montie TC; Ajl SJ
    Bacteriol Rev; 1966 Mar; 30(1):177-91. PubMed ID: 5324646
    [No Abstract]   [Full Text] [Related]  

  • 51. A Deadly Path: Bacterial Spread During Bubonic Plague.
    Gonzalez RJ; Miller VL
    Trends Microbiol; 2016 Apr; 24(4):239-241. PubMed ID: 26875618
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Uncovering an Important Role for YopJ in the Inhibition of Caspase-1 in Activated Macrophages and Promoting Yersinia pseudotuberculosis Virulence.
    Schoberle TJ; Chung LK; McPhee JB; Bogin B; Bliska JB
    Infect Immun; 2016 Apr; 84(4):1062-1072. PubMed ID: 26810037
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Eighteenth century Yersinia pestis genomes reveal the long-term persistence of an historical plague focus.
    Bos KI; Herbig A; Sahl J; Waglechner N; Fourment M; Forrest SA; Klunk J; Schuenemann VJ; Poinar D; Kuch M; Golding GB; Dutour O; Keim P; Wagner DM; Holmes EC; Krause J; Poinar HN
    Elife; 2016 Jan; 5():e12994. PubMed ID: 26795402
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Plague vaccines: new developments in an ongoing search.
    Rosenzweig JA; Hendrix EK; Chopra AK
    Appl Microbiol Biotechnol; 2021 Jun; 105(12):4931-4941. PubMed ID: 34142207
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recombinant murine toxin from Yersinia pestis shows high toxicity and β-adrenergic blocking activity in mice.
    Fan Y; Zhou Y; Feng N; Wang Q; Tian G; Wu X; Liu Z; Bi Y; Yang R; Wang X
    Microbes Infect; 2016 May; 18(5):329-35. PubMed ID: 26774329
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Murine toxin of Yersinia pestis shows phospholipase D activity but is not required for virulence in mice.
    Hinnebusch J; Cherepanov P; Du Y; Rudolph A; Dixon JD; Schwan T; Forsberg A
    Int J Med Microbiol; 2000 Oct; 290(4-5):483-7. PubMed ID: 11111930
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acquisition of yersinia murine toxin enabled Yersinia pestis to expand the range of mammalian hosts that sustain flea-borne plague.
    Bland DM; Miarinjara A; Bosio CF; Calarco J; Hinnebusch BJ
    PLoS Pathog; 2021 Oct; 17(10):e1009995. PubMed ID: 34648607
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of Yersinia murine toxin in survival of Yersinia pestis in the midgut of the flea vector.
    Hinnebusch BJ; Rudolph AE; Cherepanov P; Dixon JE; Schwan TG; Forsberg A
    Science; 2002 Apr; 296(5568):733-5. PubMed ID: 11976454
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pathology and Pathogenesis of Yersinia pestis.
    Du Z; Wang X
    Adv Exp Med Biol; 2016; 918():193-222. PubMed ID: 27722864
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.